|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Chronic hepatitis B infection in pregnancy显示文摘There are no standard guidelines to follow when a patient with chronic hepatitis B infection becomes pregnant or desires pregnancy. Topics to consider include which patients to treat, when to start treatment, what treatment to use and when to stop treatment. Without any prophylaxis or antiviral therapy, a hepatitis B surface antigen and E antigen positive mother has up to a 90% likelihood of vertical transmission of hepatitis B virus(HBV) to child. Standard of care in the United States to prevent perinatal transmission consists of administration of hepatitis B immune globulin and HBV vaccination to the infant. The two strongest risk factors of mother to child transmission(MTCT) of HBV infection despite immunoprophylaxis are high maternal HBV viral load and high activity of viral replication. The goal is to prevent transmission of HBV at birth by decreasing viral load and/or decreasing activity of the virus. Although it is still somewhat controversial, most evidence shows that starting antivirals in the third trimester is effective in decreasing MTCT without affecting fetal development. There is a growing body of literature supporting the safety and efficacy of antiviral therapies to reduce MTCT of hepatitis B. There are no formal recommendations regarding which agent to choose. Tenofovir, lamivudine and telbivudine have all been proven efficacious in decreasing viral load at birth without known birth defects, but final decision of which antiviral medication to use will have to be determined by physician and patient. The antivirals may be discontinued immediately if patient is breastfeeding, or within first four weeks if infant is being formula fed. | Jennifer R Lamberth Sheila C Reddy Jen-Jung Pan Kevin J Dasher | 2015 | World Journal of Hepatology2015，7，9： | 32 |
| 2 | A form of albinism in cattle is caused by a tyrosinase frameshift mutation显示文摘 | Sheila M Schmutz Tom G Berryere Daniel C Ciobanu | 2004 | Mammalian Genome2004，15，： | 1 |
| 3 | A form of albinism in cattle is caused by a tyrosinase frameshift mutation 显示文摘 | SHEILA M S TOM G B DANIEL C C | 2004 | MammalianGenome2004，15，： | 1 |
| 4 | The Application of Development Economics:General Principles and Context Specificity显示文摘 | Sheila C Dow | | 0，，： | 1 |
| 5 | Atrazine and Cancer Incidence Among Pesticide Applicators in the Agricultural Health Study (1994-2007)显示文摘 | Beane Freeman Laura E Rusiecki Jennifer A Hoppin Jane A Lubin Jay H Koutros Stella Andreotti Gabriella Zahm Sheila Hoar Hines Cynthia J Coble Joseph B Barone-Adesi Francesco Sloan Jennifer Sandler Dale P Blair Aaron Alavanja Michael C R | 2011 | Environmental Health Perspectives2011，，9： | 1 |
| 6 | The influence of erbium: yttrium-aluminum-garnet laser ablation with variable pulse width on morphology and microleakage of composite restorations显示文摘 | Ricardo SN Sheila GS Alessandra C et M | 2010 | Lasers Med Sci2010，25，： | 1 |
| 7 | Guidelines for the prevention of falls in people over 65显示文摘 | Gene F Colin C Sheila D | 2000 | BMJ2000，321，7267： | 1 |
| 8 | Anatomical MRI study of hippocampus and amygdala in patients with current and remitted major depression 显示文摘 | SHEILA C C JOHN P H PAOLO B | 2004 | Psychiatry Research: Neuroimaging2004，132，2： | 1 |
| 9 | CT Findings After Uterine Artery Embolization显示文摘 | Vott Subha Bonilla Sheila M Goodwin Scott C | 2000 | Journal of Computer Assisted Tomography2000，24，6： | 1 |
| 10 | Performance of a polyaniline(DMcT)/carbon fiber composite as cathode for rechargeable lithium batteries显示文摘 | SHEILA C CANOBRE ROGERIO A DAVOGLIO SONIA R BIAGGIO | 2006 | J Power Sour2006，154，1： | 1 |
| 11 | A high-performance liquid chromatographic determination of major phenolic compounds in tobacco smoke显示文摘 | CHARLES H R SHEILA L C | 1990 | J Chromatogr Sci1990，28，： | 1 |
| 12 | VSNR: A wavelet-based visual signal-to-noise ratio for natural images 显示文摘 | Damon M C Sheila S H | 2007 | IEEE Trans on Image Processing2007，16，9： | 1 |
| 13 | Capturing the contribution of subject librarians:applying strategy maps and balanced scorecards to liaison work显示文摘 | SHEILA C | 2015 | Library management2015，，3： | 1 |
| 14 | A high performance liquid chromatographic determination of major phenolic compounds in tobacco smoke 显示文摘 | Charles H R Sheila L C | 1990 | J Cbromatogr Sci1990，28，： | 1 |
| 15 | Double-blind randomized controlled study of the efficacy, safety and tolerability of eszopiclone vs placebo for the treatment of patients with post-traumatic stress disorder and insomnia显示文摘BACKGROUND Sleep disturbance is a core feature of post-traumatic stress disorder(PTSD).Given the relationship between sleep disturbance and PTSD,there has been a relative paucity of studies examining the potential therapeutic impact of using pharmacotherapy to target sleep disturbance in patients with PTSD.Eszopiclone(ESZ)is a non-benzodiazepine y-aminobutyric acid-A receptor agonist indicated for the treatment of sleep and may affect sleep in patients with PTSD.AIM To evaluate the efficacy of ESZ vs placebo(PBO)for patients with PTSD and insomnia.METHODS The study was a 12-wk,double blind,randomized controlled trial with 3 mg of ESZ(n=13)or PBO(n=12).RESULTS Patients in both arms experienced significant improvement in PTSD symptoms as assessed by the Clinician-Administered PTSD Scale for DSM-IV(CAPS):ESZ(t11=-3.12,P=0.005)and PBO(t11=-3.5,P=0.002)and by self-report with the Short PTSD Rating Interview(ESZ t11=-3.38,P=0.003 and PBO t11=-4.48,P=0.0005).There were no significant differences between treatments on the CAPS(t22=-0.13,P=0.70)or the Short PTSD Rating Interview(t22=-0.58,P=0.56).Similarly,both treated groups improved on sleep measures as assessed by the Pittsburgh Sleep Quality Index with PTSD Addendum(PSQI)and on total sleep time(TST)and sleep latency assessed by actigraphy with no significant differences between groups(PSQI t22=-0.24,P=0.81;total sleep time t10=0.13,P=0.90 and sleep latency t10=0.68,P=0.50).There was a significant correlation between improvement in sleep and overall improvement in PTSD as measured by change scores on the PSQI and CAPS,r(8)=0.79,P=0.01 for ESZ treated subjects,but not for those treated with PBO r(9)=0.16,P=0.69.Adverse events of ESZ were consistent with the known profile of the medication including dysgeusia(30%,mild),sedation(20%,mild)and headache(20%,moderate to severe).CONCLUSION Results do not support the hypothesis of a specific positive effect of ESZ compared to PBO for measures of PTSD and associated sleep disturbance. | Sheila M Dowd Alyson K Zalta Helen J Burgess Elizabeth C Adkins Zerbrina Valdespino-Hayden Mark H Pollack | 2020 | World Journal of Psychiatry2020，10，3： | 1 |
| 16 | Best practices to minimize risk of infection with intrauterine device insertion显示文摘 | Sheila C Mark HY Julie H | 2014 | Obstet Gynaecol2014，36，3： | 1 |
| 17 | A Multi- objective Optimization Model for a General Polymer Electrolyte Membrane Fuel Cell System 显示文摘 | Sheila Mae C A Daniel J L/3 Eric S F | 2010 | Jour- nal of Power Sources2010，195，9： | 1 |
| 18 | Dynamic contrast-based quantization for lossy wavelet image compression显示文摘 | DAMON M C SHEILA S H | 2005 | IEEE Transactions on Image Processing2005，14，4： | 1 |
| 19 | Identification of a Cancer stem cell in human brain tumors显示文摘 | Perer B Dirks-lan D C | 2003 | Cancer Research2003，63，： | 1 |
| 20 | Microwave effects on nervous system 显示文摘 | John A D' Andrea C K Chou Sheila A Johnston | 2003 | Bioelectromagnetics Supplement2003，6，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员